Published in Cancer Weekly, April 22nd, 2003
The results of the Phase I clinical trials of cytotoxic T-lymphocyte-associated antigen 4 blockade therapy were published online on April 1, 2003, in the early edition of the Proceedings of the National Academy of Sciences. The researchers involved in the study included James Allison, a Howard Hughes Medical Institute investigator at the University of California, Berkeley, Glenn Dranoff, Steven Hodi and colleagues from the Dana-Farber Cancer Institute (DFCI), Brigham and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.